Found: 19
Select item for more details and to access through your institution.
Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2.
- Published in:
- Advanced Science, 2022, v. 9, n. 20, p. 1, doi. 10.1002/advs.202201378
- By:
- Publication type:
- Article
Antimicrobial Activity of Cyclic-Monomeric and Dimeric Derivatives of the Snail-Derived Peptide Cm-p5 against Viral and Multidrug-Resistant Bacterial Strains.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 5, p. 745, doi. 10.3390/biom11050745
- By:
- Publication type:
- Article
New Antibacterial Peptides from the Freshwater Mollusk Pomacea poeyana (Pilsbry, 1927).
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 11, p. 1473, doi. 10.3390/biom10111473
- By:
- Publication type:
- Article
In vitro Inhibition of HIV-1 by Cyclotide-Enriched Extracts of Viola tricolor.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.888961
- By:
- Publication type:
- Article
Salivary extracellular vesicles inhibit Zika virus but not SARS-CoV-2 infection.
- Published in:
- Journal of Extracellular Vesicles, 2020, v. 9, n. 1, p. 1, doi. 10.1080/20013078.2020.1808281
- By:
- Publication type:
- Article
Salivary extracellular vesicles inhibit Zika virus but not SARS‐CoV‐2 infection.
- Published in:
- Journal of Extracellular Vesicles, 2020, v. 9, n. 1, p. 1, doi. 10.1080/20013078.2020.1808281
- By:
- Publication type:
- Article
Inhibitors of Activin Receptor-like Kinase 5 Interfere with SARS-CoV-2 S-Protein Processing and Spike-Mediated Cell Fusion via Attenuation of Furin Expression.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 6, p. N.PAG, doi. 10.3390/v14061308
- By:
- Publication type:
- Article
Storage-Dependent Generation of Potent Anti-ZIKV Activity in Human Breast Milk.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 7, p. 591, doi. 10.3390/v11070591
- By:
- Publication type:
- Article
Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19.
- Published in:
- Clinical Medicine, 2020, v. 20, n. 6, p. e218, doi. 10.7861/clinmed.2020-0351
- By:
- Publication type:
- Article
The C-terminal 32-mer fragment of hemoglobin alpha is an amyloidogenic peptide with antimicrobial properties.
- Published in:
- Cellular & Molecular Life Sciences, 2023, v. 80, n. 6, p. 1, doi. 10.1007/s00018-023-04795-8
- By:
- Publication type:
- Article
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARSCoV- 2 Omicron BA.1 in young adults.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.882918
- By:
- Publication type:
- Article
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24817-y
- By:
- Publication type:
- Article
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21972-0
- By:
- Publication type:
- Article
Erratum to: Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Nucleic Acids as a Nature‐Inspired Scaffold for Macromolecular Prodrugs of Nucleoside Analogues.
- Published in:
- Advanced Science, 2019, v. 6, n. 6, p. N.PAG, doi. 10.1002/advs.201802095
- By:
- Publication type:
- Article
Inside Back Cover Image, Volume 95, Number 1, January 2023.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 1, p. 1, doi. 10.1002/jmv.28468
- By:
- Publication type:
- Article
Native and activated antithrombin inhibits TMPRSS2 activity and SARS‐CoV‐2 infection.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 1, p. 1, doi. 10.1002/jmv.28124
- By:
- Publication type:
- Article
Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03613-4
- By:
- Publication type:
- Article